Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.
Identifieur interne : 000667 ( Main/Exploration ); précédent : 000666; suivant : 000668Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.
Auteurs : Sarah K. Abbott ; Hongyun Li ; Sonia Sanz Mu Oz ; Bianca Knoch ; Marijka Batterham ; Karen E. Murphy ; Glenda M. Halliday ; Brett GarnerSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : Oxidoreductases.
- chemical , metabolism : Ceramides.
- genetics : Parkinson Disease.
- metabolism : Brain, Parkinson Disease.
- pathology : Brain, Parkinson Disease.
- Aged, Aged, 80 and over, Female, Gene Expression, Humans, Male, Middle Aged.
Abstract
Genetic studies have provided increasing evidence that ceramide homeostasis plays a role in neurodegenerative diseases including Parkinson’s disease (PD). It is known that the relative amounts of different ceramide molecular species, as defined by their fatty acyl chain length, regulate ceramide function in lipid membranes and in signaling pathways. In the present study we used a comprehensive sphingolipidomic case-control approach to determine the effects of PD on ceramide composition in postmortem brain tissue from the anterior cingulate cortex (a region with significant PD pathology) and the occipital cortex (spared in PD), also assessing mRNA expression of the major ceramide synthase genes that regulate ceramide acyl chain composition in the same tissue using quantitative PCR. In PD anterior cingulate cortex but not occipital cortex, total ceramide and sphingomyelin levels were reduced from control levels by 53% (P < 0.001) and 42% (P < 0.001), respectively. Of the 13 ceramide and 15 sphingomyelin molecular lipid species identified and quantified, there was a significant shift in the ceramide acyl chain composition toward shorter acyl chain length in the PD anterior cingulate cortex. This PD-associated change in ceramide acyl chain composition was accompanied by an upregulation of ceramide synthase-1 gene expression, which we consider may represent a response to reduced ceramide levels. These data suggest a significant shift in ceramide function in lipid membranes and signaling pathways occurs in regions with PD pathology. Identifying the regulatory mechanisms precipitating this change may provide novel targets for future therapeutics.
PubMed: 24822250
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000503
- to stream PubMed, to step Curation: 000503
- to stream PubMed, to step Checkpoint: 000684
- to stream Ncbi, to step Merge: 003F96
- to stream Ncbi, to step Curation: 003F96
- to stream Ncbi, to step Checkpoint: 003F96
- to stream Main, to step Merge: 000667
- to stream Main, to step Curation: 000667
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.</title>
<author><name sortKey="Abbott, Sarah K" sort="Abbott, Sarah K" uniqKey="Abbott S" first="Sarah K" last="Abbott">Sarah K. Abbott</name>
</author>
<author><name sortKey="Li, Hongyun" sort="Li, Hongyun" uniqKey="Li H" first="Hongyun" last="Li">Hongyun Li</name>
</author>
<author><name sortKey="Mu Oz, Sonia Sanz" sort="Mu Oz, Sonia Sanz" uniqKey="Mu Oz S" first="Sonia Sanz" last="Mu Oz">Sonia Sanz Mu Oz</name>
</author>
<author><name sortKey="Knoch, Bianca" sort="Knoch, Bianca" uniqKey="Knoch B" first="Bianca" last="Knoch">Bianca Knoch</name>
</author>
<author><name sortKey="Batterham, Marijka" sort="Batterham, Marijka" uniqKey="Batterham M" first="Marijka" last="Batterham">Marijka Batterham</name>
</author>
<author><name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E" last="Murphy">Karen E. Murphy</name>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
</author>
<author><name sortKey="Garner, Brett" sort="Garner, Brett" uniqKey="Garner B" first="Brett" last="Garner">Brett Garner</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24822250</idno>
<idno type="pmid">24822250</idno>
<idno type="wicri:Area/PubMed/Corpus">000503</idno>
<idno type="wicri:Area/PubMed/Curation">000503</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000684</idno>
<idno type="wicri:Area/Ncbi/Merge">003F96</idno>
<idno type="wicri:Area/Ncbi/Curation">003F96</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F96</idno>
<idno type="wicri:Area/Main/Merge">000667</idno>
<idno type="wicri:Area/Main/Curation">000667</idno>
<idno type="wicri:Area/Main/Exploration">000667</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.</title>
<author><name sortKey="Abbott, Sarah K" sort="Abbott, Sarah K" uniqKey="Abbott S" first="Sarah K" last="Abbott">Sarah K. Abbott</name>
</author>
<author><name sortKey="Li, Hongyun" sort="Li, Hongyun" uniqKey="Li H" first="Hongyun" last="Li">Hongyun Li</name>
</author>
<author><name sortKey="Mu Oz, Sonia Sanz" sort="Mu Oz, Sonia Sanz" uniqKey="Mu Oz S" first="Sonia Sanz" last="Mu Oz">Sonia Sanz Mu Oz</name>
</author>
<author><name sortKey="Knoch, Bianca" sort="Knoch, Bianca" uniqKey="Knoch B" first="Bianca" last="Knoch">Bianca Knoch</name>
</author>
<author><name sortKey="Batterham, Marijka" sort="Batterham, Marijka" uniqKey="Batterham M" first="Marijka" last="Batterham">Marijka Batterham</name>
</author>
<author><name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E" last="Murphy">Karen E. Murphy</name>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
</author>
<author><name sortKey="Garner, Brett" sort="Garner, Brett" uniqKey="Garner B" first="Brett" last="Garner">Brett Garner</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Brain (metabolism)</term>
<term>Brain (pathology)</term>
<term>Ceramides (metabolism)</term>
<term>Female</term>
<term>Gene Expression</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Oxidoreductases (genetics)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (pathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Oxidoreductases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Ceramides</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Gene Expression</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Genetic studies have provided increasing evidence that ceramide homeostasis plays a role in neurodegenerative diseases including Parkinson’s disease (PD). It is known that the relative amounts of different ceramide molecular species, as defined by their fatty acyl chain length, regulate ceramide function in lipid membranes and in signaling pathways. In the present study we used a comprehensive sphingolipidomic case-control approach to determine the effects of PD on ceramide composition in postmortem brain tissue from the anterior cingulate cortex (a region with significant PD pathology) and the occipital cortex (spared in PD), also assessing mRNA expression of the major ceramide synthase genes that regulate ceramide acyl chain composition in the same tissue using quantitative PCR. In PD anterior cingulate cortex but not occipital cortex, total ceramide and sphingomyelin levels were reduced from control levels by 53% (P < 0.001) and 42% (P < 0.001), respectively. Of the 13 ceramide and 15 sphingomyelin molecular lipid species identified and quantified, there was a significant shift in the ceramide acyl chain composition toward shorter acyl chain length in the PD anterior cingulate cortex. This PD-associated change in ceramide acyl chain composition was accompanied by an upregulation of ceramide synthase-1 gene expression, which we consider may represent a response to reduced ceramide levels. These data suggest a significant shift in ceramide function in lipid membranes and signaling pathways occurs in regions with PD pathology. Identifying the regulatory mechanisms precipitating this change may provide novel targets for future therapeutics.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Abbott, Sarah K" sort="Abbott, Sarah K" uniqKey="Abbott S" first="Sarah K" last="Abbott">Sarah K. Abbott</name>
<name sortKey="Batterham, Marijka" sort="Batterham, Marijka" uniqKey="Batterham M" first="Marijka" last="Batterham">Marijka Batterham</name>
<name sortKey="Garner, Brett" sort="Garner, Brett" uniqKey="Garner B" first="Brett" last="Garner">Brett Garner</name>
<name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
<name sortKey="Knoch, Bianca" sort="Knoch, Bianca" uniqKey="Knoch B" first="Bianca" last="Knoch">Bianca Knoch</name>
<name sortKey="Li, Hongyun" sort="Li, Hongyun" uniqKey="Li H" first="Hongyun" last="Li">Hongyun Li</name>
<name sortKey="Mu Oz, Sonia Sanz" sort="Mu Oz, Sonia Sanz" uniqKey="Mu Oz S" first="Sonia Sanz" last="Mu Oz">Sonia Sanz Mu Oz</name>
<name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E" last="Murphy">Karen E. Murphy</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000667 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000667 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24822250 |texte= Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24822250" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |